Vertex Pharmaceuticals, Inc.’s recently made public that its EVP and Chief Legal Officer Biller Jonathan unloaded Company’s shares for reported $0.46 million on Oct 02 ’24. In the deal valued at $461.66 per share,999 shares were sold. As a result of this transaction, Biller Jonathan now holds 16,651 shares worth roughly $7.58 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Biller Jonathan bought 999 shares, generating $461,198 in total proceeds.
Before that, LEIDEN JEFFREY M sold 3,784 shares. Vertex Pharmaceuticals, Inc. shares valued at $1,888,216 were divested by the Executive Chairman at a price of $499.00 per share. As a result of the transaction, LEIDEN JEFFREY M now holds 9,994 shares, worth roughly $4.55 million.
Barclays downgraded its Vertex Pharmaceuticals, Inc. [VRTX] rating to an Equal weight from a an Overweight in a research note published on August 05, 2024; the price target was increased to $509 from $472. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. Evercore ISI also remained covering VRTX and has increased its forecast on April 11, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. Wolfe Research started covering the stock on February 15, 2024. It rated VRTX as “an Outperform”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc. [NASDAQ:VRTX] saw its stock jump 0.39% to $455.31. Over the last five days, the stock has lost -1.64%. Vertex Pharmaceuticals, Inc. shares have risen nearly 11.90% since the year began. Nevertheless, the stocks have risen 28.99% over the past one year. While a 52-week high of $510.64 was reached on 08/01/24, a 52-week low of $341.90 was recorded on 04/18/24. SMA at 50 days reached $476.73, while 200 days put it at $444.79.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 452.57, which if violated will result in even more drops to 449.84. On the upside, there is a resistance level at 458.09. A further resistance level may holdings at 460.88. The Relative Strength Index (RSI) on the 14-day chart is 38.19, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -8.35, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.28%. Stochastics %K at 9.98% indicates the stock is a buying.
How much short interest is there in Vertex Pharmaceuticals, Inc.?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc. stocks on 2024-09-13, dropping by 88473.0 shares to a total of 4.34 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 4.42 million shares. There was a decline of -2.04%, which implies that there is a negative sentiment for the stock.
